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ABSTRACT
Penicillinase testing is required for Staphylococcus
aureus isolates with a penicillin MIC of
£0.12 mg ⁄L. This study compared five pheno-
typic assays with a PCR for blaZ when testing 197
S. aureus isolates. The starch–iodine plate method
and nitrocefin tests had low sensitivities of 42.9%
and 35.7%, respectively. The cloverleaf assay and
the penicillin zone-edge determination method
had sensitivities of 67.8% and 71.4%, respec-
tively, and these methods might be appropriate in
many circumstances, but were not as sensitive as
blaZ PCR.
Keywords blaZ, PCR, penicillinase, phenotypic assays,
sensitivity testing, Staphylococcus aureus
Original Submission: 16 October 2007; Revised Sub-
mission: 28 January 2008; Accepted: 4 February 2008
Clin Microbiol Infect 2008; 14: 614–616
10.1111/j.1469-0691.2008.01997.x
Resistance to penicillin in Staphylococcus aureus is
mediated by production of a penicillinase,
encoded by blaZ. Four types of penicillinase
(termed A–D) have been described in S. aureus,
all of which are Ambler class A b-lactamases [1].
Reliable detection of penicillinase production is
important because penicillin is considered to be
superior to oxacillin against isolates that do not
produce a penicillinase. An erroneus report of
penicillin susceptibility could result in potentially
inadequate therapy of S. aureus infections. A
penicillin MIC of £0.12 mg ⁄L is formally in the
sensitive range, but the CLSI recommends that
additional testing should be performed [2]. The
aim of the present study was to compare five
phenotypic methods for penicillinase detection,
i.e., penicillin disk-diffusion, penicillin zone-edge
determination, a cloverleaf assay, nitrocefin tests
and a starch–iodine plate method, against a PCR
assay for blaZ when testing the sub-population of
isolates with a penicillin MIC in the formally
sensitive range according to the Vitek 2 system
(bioMe´rieux, Durham, NC, USA).
Consecutive non-duplicate isolates of S. aureus
(n = 197) were collected if their penicillin MIC
according to Vitek 2 was £0.12 mg ⁄L. Disk-
diffusion tests for penicillin were performed
according to CLSI recommendations [2] (10-U
disk; Oxoid, Basingstoke, UK). The penicillin
zone-edge was checked for a sharp edge with
discrete full-sized colonies right at the edge, or for
a tapered edge with a gradual decrease in growth
[3]. A sharp edge was considered to be indicative
of penicillinase production. Zone inhibition diam-
eters were measured, with a diameter of £28 mm
for penicillin being considered to be penicillinase-
positive [2]. The cloverleaf assay was performed
as described previously [4], except that S. aureus
ATCC 25923 was used as the indicator strain on
Mueller–Hinton agar (Merck, Darmstadt, Ger-
many). Testing with nitrocefin sticks (Oxoid)
was performed according to the manufacturer’s
instructions, with colonies located at the penicillin
zone-edge, and was read after 5, 15 and 60 min.
The starch–iodine plate method was performed as
described previously [4], except that oxacillin
(Sigma, Taufkirchen, Germany) 0.2 mg ⁄L was
used for penicillinase induction instead of meth-
icillin. Decolourisation under and around the
colonies was considered to be a positive result.
Primers for amplification of blaZ, designed
according to blaZ sequences published previ-
ously, were stau-blaZ-fwd (5¢-CAAAGATGA
TATAGTTGCTTATTCTCC) and stau-blaZ-rev
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(5¢-TGCTTGACCACTTTTATCAGC). PCRs were
performed in 50-lL volumes containing 200 lM
each dNTP, 1 lM each primer, 10 lL template
DNA, 1.25 U Taq polymerase (GE Healthcare,
Munchen, Germany) and the reaction buffer
supplied by the manufacturer. Cycling conditions
comprised 94C for 5 min, followed by 35 cycles
of 94C for 30 s, 50C for 30 s and 72C for 30 s,
with a final extension at 72C for 7 min. The PCR
was evaluated with known S. aureus strains pro-
ducing penicillinases A–D [1], kindly provided
by D. Kernodle (Vanderbilt University, Nashville,
TN, USA). The S. aureus-specific PCR for SA442
[5] was also performed for all isolates as a control.
Of 197 S. aureus isolates with a penicillin MIC
of £0.12 mg ⁄L according to Vitek 2, 28 (14.2%)
were positive for blaZ according to the PCR assay.
All isolates with a penicillin MIC of 0.03 mg ⁄L
according to Vitek 2 were blaZ-negative. Five
(6.2%) of 81 isolates with a penicillin MIC of
0.06 mg ⁄L, and 23 (23.2%) of 99 isolates with a
penicillin MIC of 0.12 mg ⁄L were blaZ-positive.
Of all 28 blaZ-positive isolates, 19 (67.8%) were
detected in the cloverleaf assay, 20 (71.4%) were
detected by zone-edge determination, 12 (42.9%)
were detected by the starch–iodine plate method,
and seven (25%), ten (35.7%) and 11 (39.3%) were
detected by the nitrocefin assay after incubation
for 5, 15 and 60 min, respectively. The use of a
breakpoint of £28 mm in penicillin disk-diffusion
tests, recommended by the CLSI for categorising
an isolate as penicillin-resistant [2], resulted in a
sensitivity of 57.1%. Overlapping zone inhibition
diameters for blaZ-positive and -negative isolates
were found for penicillin (Fig. 1). None of the
isolates that had a positive phenotypic test for
penicillinase production was negative according
to the blaZ PCR assay.
In contrast to previous reports, an unaccept-
ably low sensitivity of 39.3% was found for
nitrocefin tests, even after induction by penicillin
and incubation for 60 min. Sensitivities reported
previously for nitrocefin tests were 82% [6],
86.2% [7], 95.6% [8], 70.8–97.9%, depending on
the induction method and agar used [4], and 62.1–
100%, depending on the manufacturer of the
nitrocefin assay [9]. In addition, a sensitivity of
100% has been reported previously for the starch–
iodine plate method following penicillinase
induction [4]. In the present study, the most
sensitive phenotypic tests were penicillin zone-
edge determination (71.4%) and the cloverleaf
assay (67.8%). Sensitivities of 93.8% [8], 97.9% [4]
and 96.6% [9] for the cloverleaf assay have been
reported previously. Overlapping inhibition zone
diameters for blaZ-positive and -negative isolates
were found when performing disk-diffusion with
penicillin disks, also as reported previously.
Isolates with a zone diameter of £28 mm, as
recommended by CLSI [2], were all blaZ-positive
in the present study, but a larger diameter did not
exclude the presence of blaZ.
The reduced sensitivities of phenotypic tests in
the present study might have been caused by the
Fig. 1. Inhibition zone diameters
obtained with a 10-U penicillin disk
in disk-diffusion tests performed
according to CLSI recommendations
[2].
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use of a highly selected collection of isolates, all of
which had a low penicillin MIC according to
Vitek 2. In contrast to previous studies, a molec-
ular method was used as the reference standard.
Pitka¨la¨ et al. [9] also used PCR detection of blaZ as
the reference standard, but only with bovine
S. aureus isolates.
In conclusion, the results of this study discour-
age the use of nitrocefin tests or the starch–iodine
plate method as additional assays for isolates with
penicillin MICs of 0.06 or 0.12 mg ⁄L according to
the Vitek 2 system. Higher sensitivities were
found for penicillin zone-edge determination and
the cloverleaf assay, but it might be insufficient to
report an isolate from a serious infection as
penicillin-sensitive without performing a PCR to
detect blaZ.
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ABSTRACT
This study determined the types of AmpC
enzymesproduced byKlebsiella pneumoniae isolates
resistant to third-generation cephalosporins and
the clonality of these isolates. The presence of
AmpC enzymes was identified by cephalosporin–
cloxacillin synergy tests. Genes encoding AmpC
enzymes were characterised by PCR and sequenc-
ing. Pulsed-field gel electrophoresis (PFGE) was
used to type the isolates. Fifteen K. pneumoniae
isolates were positive for blaAmpC, 13 were positive
for blaACC-1 and two were positive for blaDHA-1.
Production of the DHA-1 enzyme was inducible.
The ampR gene was identified upstream of the
blaDHA-1 gene. PFGE demonstrated the polyclonal
origin of the isolates carrying blaACC-1.
Keywords ACC-1, AmpC b-lactamase, DHA-1, Kleb-
siella pneumoniae, resistance, typing
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